Know Labs Files 8-K: Agreements, Officer Changes, and Filings
Ticker: USBC · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1074828
| Field | Detail |
|---|---|
| Company | Know Labs, Inc. (USBC) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, officer-changes, director-changes
Related Tickers: KNOW
TL;DR
KNOW filed an 8-K detailing new deals, exec changes, and equity sales. Watch for updates.
AI Summary
Know Labs, Inc. announced on June 5, 2025, a material definitive agreement and unregistered sales of equity securities. The company also reported the departure of directors or certain officers, the election of directors, and the appointment of certain officers, along with compensatory arrangements. Additionally, a Regulation FD Disclosure was made, and financial statements and exhibits were filed.
Why It Matters
This 8-K filing indicates significant corporate actions including new agreements, potential equity dilution, and changes in leadership, which could impact the company's strategic direction and investor outlook.
Risk Assessment
Risk Level: medium — The filing mentions unregistered sales of equity securities and changes in directors/officers, which can introduce uncertainty and potential dilution.
Key Players & Entities
- KNOW LABS, INC. (company) — Registrant
- June 5, 2025 (date) — Date of earliest event reported
- 0001074828 (company) — Central Index Key
- NV (state) — State of Incorporation
- 0930 (date) — Fiscal Year End
- SEATTLE (city) — Business Address City
- WA (state) — Business Address State
- 98104 (zip_code) — Business Address Zip
- 206-903-1351 (phone_number) — Business Phone
FAQ
What type of material definitive agreement was entered into by Know Labs, Inc.?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this excerpt.
What is the significance of the 'Unregistered Sales of Equity Securities' item?
This item suggests that Know Labs, Inc. has sold equity securities without registering them with the SEC, which could have implications for dilution and investor rights.
Were there any changes in the company's board of directors or executive officers?
Yes, the filing reports the departure of directors or certain officers, the election of directors, and the appointment of certain officers.
What is the company's fiscal year end?
Know Labs, Inc.'s fiscal year ends on September 30 (0930).
What is the business address of Know Labs, Inc.?
The business address is 619 Western Avenue, Suite 610, Seattle, WA 98104.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding KNOW LABS, INC. (USBC).